Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Angewandte Chemie (International Ed. in English)|May 2, 2018
Total Synthesis of (-)-Tetrazomine and Determination of Its StereochemistryJack D Scott, Robert M Williams
Organic Letters|October 27, 2023
Synthesis of DNA-Encoded Macrocyclic Peptides via Nitrile-Aminothiol Click ReactionLijun Fan, Yang Yu, Charles Jayne, et al.
Bioorganic & Medicinal Chemistry|April 11, 2021
Development of DNA-compatible hydroxycarbonylation reactions using chloroform as a source of carbon monoxideWentao Liu, Wei Huang, Qian Lin, et al.
European Journal of Pharmacology|March 8, 2014
Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behaviorRobert A Hodgson, Deborra Mullins, Sherry X Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2009
Diaryl piperidines as CB1 receptor antagonistsJack D Scott, Sarah W Li, Hongwu Wang, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2009
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonistsJack D Scott, Michael W Miller, Sarah W Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.
Science Translational Medicine|November 4, 2016
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patientsMatthew E Kennedy, Andrew W Stamford, Xia Chen, et al.
ACS Medicinal Chemistry Letters|February 16, 2013
Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor that Affords Robust CNS Aβ ReductionAndrew W Stamford, Jack D Scott, Sarah W Li, et al.
Pageof 2